SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Gulo who wrote (14333)11/24/2004 12:53:14 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 52153
 
we've followed the project for years in the NBIX thread. NBIX had a sister project. We determined early that NBIX would likely be looking at a fraction of the NEOL-recognized receptors.

Miljenko isn't commenting from perspective of a single PR, but from years of watching this project and that of NBIX. don't know if you'd find anything in the NBIX thread that you don't already know.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News